Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6671850rdf:typepubmed:Citationlld:pubmed
pubmed-article:6671850lifeskim:mentionsumls-concept:C0029445lld:lifeskim
pubmed-article:6671850lifeskim:mentionsumls-concept:C0040405lld:lifeskim
pubmed-article:6671850lifeskim:mentionsumls-concept:C0015813lld:lifeskim
pubmed-article:6671850lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:6671850lifeskim:mentionsumls-concept:C0070139lld:lifeskim
pubmed-article:6671850pubmed:issue3lld:pubmed
pubmed-article:6671850pubmed:dateCreated1984-5-17lld:pubmed
pubmed-article:6671850pubmed:abstractTextPrecise evaluation of bone loss and bone viability is necessary in order to select the most appropriate operation for patients with osteonecrosis of the femoral head. Bone destruction, and its exact location, can be assessed by computed axial tomography. The viability of remaining bone can be observed at operation by systemic vital staining with Disulphine Blue.lld:pubmed
pubmed-article:6671850pubmed:languageenglld:pubmed
pubmed-article:6671850pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6671850pubmed:citationSubsetIMlld:pubmed
pubmed-article:6671850pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6671850pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6671850pubmed:statusMEDLINElld:pubmed
pubmed-article:6671850pubmed:issn0341-2695lld:pubmed
pubmed-article:6671850pubmed:authorpubmed-author:OpdecamPPlld:pubmed
pubmed-article:6671850pubmed:authorpubmed-author:CasteleynP...lld:pubmed
pubmed-article:6671850pubmed:authorpubmed-author:De BoeckHHlld:pubmed
pubmed-article:6671850pubmed:authorpubmed-author:HandelbergFFlld:pubmed
pubmed-article:6671850pubmed:issnTypePrintlld:pubmed
pubmed-article:6671850pubmed:volume7lld:pubmed
pubmed-article:6671850pubmed:ownerNLMlld:pubmed
pubmed-article:6671850pubmed:authorsCompleteYlld:pubmed
pubmed-article:6671850pubmed:pagination149-52lld:pubmed
pubmed-article:6671850pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6671850pubmed:meshHeadingpubmed-meshheading:6671850-...lld:pubmed
pubmed-article:6671850pubmed:meshHeadingpubmed-meshheading:6671850-...lld:pubmed
pubmed-article:6671850pubmed:meshHeadingpubmed-meshheading:6671850-...lld:pubmed
pubmed-article:6671850pubmed:meshHeadingpubmed-meshheading:6671850-...lld:pubmed
pubmed-article:6671850pubmed:meshHeadingpubmed-meshheading:6671850-...lld:pubmed
pubmed-article:6671850pubmed:meshHeadingpubmed-meshheading:6671850-...lld:pubmed
pubmed-article:6671850pubmed:meshHeadingpubmed-meshheading:6671850-...lld:pubmed
pubmed-article:6671850pubmed:meshHeadingpubmed-meshheading:6671850-...lld:pubmed
pubmed-article:6671850pubmed:meshHeadingpubmed-meshheading:6671850-...lld:pubmed
pubmed-article:6671850pubmed:year1983lld:pubmed
pubmed-article:6671850pubmed:articleTitleComputed axial tomography and Disulphine Blue in the evaluation of osteonecrosis of the femoral head.lld:pubmed
pubmed-article:6671850pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6671850pubmed:publicationTypeCase Reportslld:pubmed